Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13740 | 816 | 40.9 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
17 | 4 | REPRODUCTIVE BIOLOGY//OBSTETRICS & GYNECOLOGY//VETERINARY SCIENCES | 563730 |
132 | 3 | REPRODUCTIVE BIOLOGY//FERTILITY AND STERILITY//OBSTETRICS & GYNECOLOGY | 66807 |
3005 | 2 | ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//LHRH RECEPTOR | 2547 |
13740 | 1 | LHRH RECEPTOR//ENDOCRINE POLYPEPTIDE CANC//CYTOTOXIC LHRH ANALOG | 816 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LHRH RECEPTOR | authKW | 934557 | 4% | 78% | 32 |
2 | ENDOCRINE POLYPEPTIDE CANC | address | 662769 | 8% | 29% | 62 |
3 | CYTOTOXIC LHRH ANALOG | authKW | 374194 | 1% | 100% | 10 |
4 | TARGETED CHEMOTHERAPY | authKW | 291232 | 3% | 32% | 24 |
5 | SECT EXPT MED | address | 267904 | 4% | 22% | 32 |
6 | AN 152 | authKW | 266091 | 1% | 89% | 8 |
7 | TARGETED CANCER CHEMOTHERAPY | authKW | 224516 | 1% | 100% | 6 |
8 | GONADOTROPIN RELEASING HORMONE RECEPTOR | authKW | 208332 | 3% | 24% | 23 |
9 | AEZS 108 | authKW | 187097 | 1% | 100% | 5 |
10 | GNRH RECEPTOR | authKW | 168336 | 4% | 15% | 30 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 4214 | 38% | 0% | 308 |
2 | Endocrinology & Metabolism | 4104 | 28% | 0% | 227 |
3 | Obstetrics & Gynecology | 871 | 11% | 0% | 86 |
4 | Reproductive Biology | 399 | 5% | 0% | 38 |
5 | Pharmacology & Pharmacy | 258 | 13% | 0% | 104 |
6 | Urology & Nephrology | 167 | 5% | 0% | 40 |
7 | Biochemistry & Molecular Biology | 97 | 14% | 0% | 111 |
8 | Chemistry, Medicinal | 72 | 4% | 0% | 29 |
9 | Medicine, Research & Experimental | 51 | 4% | 0% | 34 |
10 | Cell Biology | 13 | 4% | 0% | 35 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOCRINE POLYPEPTIDE CANC | 662769 | 8% | 29% | 62 |
2 | SECT EXPT MED | 267904 | 4% | 22% | 32 |
3 | ANALYT CHEM BIOPOLYMER STRUCT ANAL | 110925 | 2% | 23% | 13 |
4 | BIOTECHNOL INCUBATING GOLDEN HELIX | 74839 | 0% | 100% | 2 |
5 | MED MED SECT EXPT MED | 74839 | 0% | 100% | 2 |
6 | MULTIDISCIPLINARY GYNECOL ONCOL | 49891 | 0% | 67% | 2 |
7 | ENDOCRINOL ONCOL | 41559 | 1% | 11% | 10 |
8 | ASSISTANCE HOP PB | 37419 | 0% | 100% | 1 |
9 | BARKING | 37419 | 0% | 100% | 1 |
10 | BOLSHOI PROEZD 31 | 37419 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF ONCOLOGY | 3985 | 4% | 0% | 32 |
2 | PROSTATE | 2642 | 2% | 0% | 18 |
3 | ANTI-CANCER DRUGS | 2225 | 2% | 0% | 14 |
4 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1780 | 4% | 0% | 34 |
5 | ENDOCRINE-RELATED CANCER | 1435 | 1% | 0% | 8 |
6 | ONCOLOGY REPORTS | 1334 | 2% | 0% | 19 |
7 | BREAST CANCER RESEARCH AND TREATMENT | 1298 | 2% | 0% | 16 |
8 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 1022 | 1% | 0% | 12 |
9 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 680 | 2% | 0% | 13 |
10 | SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY | 638 | 0% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LHRH RECEPTOR | 934557 | 4% | 78% | 32 | Search LHRH+RECEPTOR | Search LHRH+RECEPTOR |
2 | CYTOTOXIC LHRH ANALOG | 374194 | 1% | 100% | 10 | Search CYTOTOXIC+LHRH+ANALOG | Search CYTOTOXIC+LHRH+ANALOG |
3 | TARGETED CHEMOTHERAPY | 291232 | 3% | 32% | 24 | Search TARGETED+CHEMOTHERAPY | Search TARGETED+CHEMOTHERAPY |
4 | AN 152 | 266091 | 1% | 89% | 8 | Search AN+152 | Search AN+152 |
5 | TARGETED CANCER CHEMOTHERAPY | 224516 | 1% | 100% | 6 | Search TARGETED+CANCER+CHEMOTHERAPY | Search TARGETED+CANCER+CHEMOTHERAPY |
6 | GONADOTROPIN RELEASING HORMONE RECEPTOR | 208332 | 3% | 24% | 23 | Search GONADOTROPIN+RELEASING+HORMONE+RECEPTOR | Search GONADOTROPIN+RELEASING+HORMONE+RECEPTOR |
7 | AEZS 108 | 187097 | 1% | 100% | 5 | Search AEZS+108 | Search AEZS+108 |
8 | GNRH RECEPTOR | 168336 | 4% | 15% | 30 | Search GNRH+RECEPTOR | Search GNRH+RECEPTOR |
9 | GNRH III | 133638 | 1% | 71% | 5 | Search GNRH+III | Search GNRH+III |
10 | TARGETED CHEMOTHERAPEUTIC AGENTS | 133638 | 1% | 71% | 5 | Search TARGETED+CHEMOTHERAPEUTIC+AGENTS | Search TARGETED+CHEMOTHERAPEUTIC+AGENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LIMONTA, P , MARELLI, MM , MAI, S , MOTTA, M , MARTINI, L , MORETTI, RM , (2012) GNRH RECEPTORS IN CANCER: FROM CELL BIOLOGY TO NOVEL TARGETED THERAPEUTIC STRATEGIES.ENDOCRINE REVIEWS. VOL. 33. ISSUE 5. P. 784 -811 | 131 | 49% | 30 |
2 | LIMONTA, P , MANEA, M , (2013) GONADOTROPIN-RELEASING HORMONE RECEPTORS AS MOLECULAR THERAPEUTIC TARGETS IN PROSTATE CANCER: CURRENT OPTIONS AND EMERGING STRATEGIES.CANCER TREATMENT REVIEWS. VOL. 39. ISSUE 6. P. 647 -663 | 110 | 47% | 20 |
3 | NAGY, A , SCHALLY, AV , (2005) TARGETING OF CYTOTOXIC LUTEINIZING HORMONE-RELEASING HORMONE ANALOGS TO BREAST, OVARIAN, ENDOMETRIAL, AND PROSTATE CANCERS.BIOLOGY OF REPRODUCTION. VOL. 73. ISSUE 5. P. 851-859 | 68 | 86% | 78 |
4 | SO, WK , CHENG, JC , POON, SL , LEUNG, PCK , (2008) GONADOTROPIN-RELEASING HORMONE AND OVARIAN CANCER: A FUNCTIONAL AND MECHANISTIC OVERVIEW.FEBS JOURNAL. VOL. 275. ISSUE 22. P. 5496 -5511 | 81 | 70% | 20 |
5 | AGUILAR-ROJAS, A , HUERTA-REYES, M , (2009) HUMAN GONADOTROPIN-RELEASING HORMONE RECEPTOR-ACTIVATED CELLULAR FUNCTIONS AND SIGNALING PATHWAYS IN EXTRA-PITUITARY TISSUES AND CANCER CELLS (REVIEW).ONCOLOGY REPORTS. VOL. 22. ISSUE 5. P. 981 -990 | 80 | 58% | 27 |
6 | CHEUNG, LWT , WONG, AST , (2008) GONADOTROPIN-RELEASING HORMONE: GNRH RECEPTOR SIGNALING IN EXTRAPITUITARY TISSUES.FEBS JOURNAL. VOL. 275. ISSUE 22. P. 5479 -5495 | 77 | 53% | 58 |
7 | ENGEL, JB , TINNEBERG, HR , RICK, FG , BERKES, E , SCHALLY, AV , (2016) TARGETING OF PEPTIDE CYTOTOXINS TO LHRH RECEPTORS FOR TREATMENT OF CANCER.CURRENT DRUG TARGETS. VOL. 17. ISSUE 5. P. 488 -494 | 39 | 95% | 0 |
8 | AGUILAR-ROJAS, A , PEREZ-SOLIS, MA , MAYA-NUNEZ, G , (2016) THE GONADOTROPIN-RELEASING HORMONE SYSTEM: PERSPECTIVES FROM REPRODUCTION TO CANCER.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 48. ISSUE 3. P. 861 -868 | 51 | 59% | 1 |
9 | MARELLI, MM , MORETTI, RM , JANUSZKIEWICZ-CAULIER, J , MOTTA, M , LIMONTA, P , (2006) GONADOTROPIN-RELEASING HORMONE (GNRH) RECEPTORS IN TUMORS: A NEW RATIONALE FOR THE THERAPEUTICAL APPLICATION OF GNRH ANALOGS IN CANCER PATIENTS?.CURRENT CANCER DRUG TARGETS. VOL. 6. ISSUE 3. P. 257-269 | 75 | 51% | 26 |
10 | NAGY, A , SCHALLY, AV , (2002) CYTOTOXIC ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE (LHRH): A NEW APPROACH TO TARGETED CHEMOTHERAPY.DRUGS OF THE FUTURE. VOL. 27. ISSUE 4. P. 359 -370 | 51 | 84% | 13 |
Classes with closest relation at Level 1 |